These tumors occur in older individuals compared to IDH-wildtype lower-grade astrocytomas or IDH-mutant glioblastomas, have shorter clinical history, and shorter post-surgical survival intervals [4,7,52,105,106], although long-surviving patients are represented in the literature [137]. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).